ARS Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$4.01M Sell
24,326
-448
-2% -$74.2K 0.72% 33
2021
Q1
$4.07M Sell
24,774
-299
-1% -$48.4K 0.89% 29
2020
Q4
$3.95M Buy
25,073
+189
+0.8% +$27.9K 0.85% 26
2020
Q3
$3.71M Buy
24,884
+91
+0.4% +$13.5K 1.02% 22
2020
Q2
$3.49M Sell
24,793
-131
-0.5% -$19.1K 1.09% 18
2020
Q1
$3.27M Sell
24,924
-1,082
-4% -$154K 1.38% 13
2019
Q4
$3.79M Sell
26,006
-326
-1% -$44.2K 1.1% 18
2019
Q3
$3.41M Sell
26,332
-948
-3% -$125K 1.08% 17
2019
Q2
$3.8M Buy
27,280
+3,655
+15% +$506K 1.21% 17
2019
Q1
$3.3M Sell
23,625
-715
-3% -$95.8K 1.05% 17
2018
Q4
$3.14M Sell
24,340
-652
-3% -$90.9K 1.15% 17
2018
Q3
$3.45M Buy
24,992
+1,344
+6% +$179K 1.16% 17
2018
Q2
$2.87M Buy
23,648
+122
+0.5% +$15.2K 1.03% 18
2018
Q1
$3.02M Buy
23,526
+1,410
+6% +$191K 1.12% 18
2017
Q4
$3.09M Sell
22,116
-155
-0.7% -$21.6K 1.15% 19
2017
Q3
$2.9M Buy
22,271
+2,896
+15% +$384K 1.12% 21
2017
Q2
$2.56M Buy
19,375
+2,264
+13% +$289K 1.04% 20
2017
Q1
$2.13M Sell
17,111
-11,113
-39% -$1.33M 0.91% 23
2016
Q4
$3.25M Sell
28,224
-887
-3% -$102K 1.46% 13
2016
Q3
$3.44M Buy
29,111
+1,968
+7% +$239K 1.46% 15
2016
Q2
$3.29M Buy
27,143
+3,345
+14% +$380K 1.4% 15
2016
Q1
$2.58M Buy
23,798
+3,296
+16% +$341K 1.21% 16
2015
Q4
$2.11M Buy
20,502
+14,596
+247% +$1.47M 1.08% 14
2015
Q3
$551K Buy
5,906
+16
+0.3% +$1.55K 0.28% 31
2015
Q2
$574K Buy
5,890
+489
+9% +$49K 0.25% 30
2015
Q1
$543K Sell
5,401
-130
-2% -$13.2K 0.23% 33
2014
Q4
$578K Sell
5,531
-50
-0.9% -$5.27K 0.25% 34
2014
Q3
$595K Sell
5,581
-61
-1% -$6.33K 0.28% 31
2014
Q2
$590K Buy
5,642
+2,672
+90% +$270K 0.29% 31
2014
Q1
$292K Sell
2,970
-435
-13% -$40.3K 0.18% 42
2013
Q4
$312K Buy
+3,405
New +$314K 0.19% 41

Other funds holding JNJ

ARS Wealth Advisors's JNJ Position: Q2 2021 in Review

ARS Wealth Advisors reduced its Johnson & Johnson (JNJ) stake by 1.8% in Q2 2021, selling an estimated $74.2K and leaving 24,326 shares worth $4.01M. The position accounts for 0.72% of the portfolio, ranked #33.

ARS Wealth Advisors first reported a position in JNJ in Q4 2013 and has held it in 31 quarters since. The position peaked at $4.07M in Q1 2021. 3,325 funds tracked by Wall St. Rank hold JNJ as of Q2 2021.

  • ARS Wealth Advisors held 24,326 shares of Johnson & Johnson worth $4.01M as of Q2 2021.
  • ARS Wealth Advisors sold 448 Johnson & Johnson shares in Q2 2021, an estimated $74.2K.
  • Johnson & Johnson made up 0.72% of ARS Wealth Advisors's portfolio in Q2 2021, its #33 holding.
  • ARS Wealth Advisors first reported a position in Johnson & Johnson in Q4 2013 and has held it in 31 quarters since.
  • ARS Wealth Advisors's Johnson & Johnson position peaked at $4.07M in Q1 2021.
  • 3,325 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2021.

Based on ARS Wealth Advisors's 13F filing for Q2 2021, filed 15 Jul 2021.